Kelley V - Search Results

1

OST Catalytic Subunit Redundancy Enables Therapeutic Targeting of N-Glycosylation.

Baro M, Lee H, Kelley V, Lou R, Phoomak C, Politi K, Zeiss CJ, Van Zandt M, Contessa JN. Baro M, et al. Among authors: kelley v. bioRxiv [Preprint]. 2024 Dec 5:2024.12.03.626593. doi: 10.1101/2024.12.03.626593. bioRxiv. 2024. PMID: 39677793 Free PMC article. Preprint.

2

Understanding period poverty and stigma: Highlighting the need for improved public health initiatives and provider awareness.

Miller TA, Farley M, Reji J, Obeidi Y, Kelley V, Herbert M. Miller TA, et al. Among authors: kelley v. J Am Pharm Assoc (2003). 2024 Jan-Feb;64(1):218-221. doi: 10.1016/j.japh.2023.10.015. Epub 2023 Oct 19. J Am Pharm Assoc (2003). 2024. PMID: 37863396

3

Rational Design and Optimization of m⁶A-RNA Demethylase FTO Inhibitors as Anticancer Agents.

Huff S, Kummetha IR, Zhang L, Wang L, Bray W, Yin J, Kelley V, Wang Y, Rana TM. Huff S, et al. Among authors: kelley v. J Med Chem. 2022 Aug 25;65(16):10920-10937. doi: 10.1021/acs.jmedchem.1c02075. Epub 2022 Aug 8. J Med Chem. 2022. PMID: 35939803 Free PMC article.

4

IL-34 and protein-tyrosine phosphatase receptor type-zeta-dependent mechanisms limit arthritis in mice.

González-Sánchez HM, Baek JH, Weinmann-Menke J, Ajay AK, Charles JF, Noda M, Franklin RA, Rodríguez-Morales P, Kelley VR. González-Sánchez HM, et al. Among authors: kelley vr. Lab Invest. 2022 Aug;102(8):846-858. doi: 10.1038/s41374-022-00772-0. Epub 2022 Mar 14. Lab Invest. 2022. PMID: 35288653 Free article.

5

Exploring the Usability of a Community Resiliency Model Approach in a High Need/Low Resourced Traumatized Community.

Freeman K, Baek K, Ngo M, Kelley V, Karas E, Citron S, Montgomery S. Freeman K, et al. Among authors: kelley v. Community Ment Health J. 2022 May;58(4):679-688. doi: 10.1007/s10597-021-00872-z. Epub 2021 Jul 9. Community Ment Health J. 2022. PMID: 34241738

6

IL-34-Dependent Intrarenal and Systemic Mechanisms Promote Lupus Nephritis in MRL-Fas^lpr Mice.

Wada Y, Gonzalez-Sanchez HM, Weinmann-Menke J, Iwata Y, Ajay AK, Meineck M, Kelley VR. Wada Y, et al. Among authors: kelley vr. J Am Soc Nephrol. 2019 Feb;30(2):244-259. doi: 10.1681/ASN.2018090901. Epub 2019 Jan 8. J Am Soc Nephrol. 2019. PMID: 30622154 Free PMC article.

7

Dysferlinopathy Promotes an Intramuscle Expansion of Macrophages with a Cyto-Destructive Phenotype.

Baek JH, Many GM, Evesson FJ, Kelley VR. Baek JH, et al. Among authors: kelley vr. Am J Pathol. 2017 Jun;187(6):1245-1257. doi: 10.1016/j.ajpath.2017.02.011. Epub 2017 Apr 13. Am J Pathol. 2017. PMID: 28412297 Free article.

8

Hospital and Health Plan Partnerships: The Affordable Care Act's Impact on Promoting Health and Wellness.

Vu M, White A, Kelley VP, Hopper JK, Liu C. Vu M, et al. Among authors: kelley vp. Am Health Drug Benefits. 2016 Jul;9(5):269-78. Am Health Drug Benefits. 2016. PMID: 27625744 Free PMC article.

9

Predictors of surgical outcome in medically-resistant temporal lobe epilepsy with bilateral features on pre-operative evaluation.

Waseem H, Osborn KE, Schoenberg MR, Kelley V, Bozorg AM, Benbadis SR, Vale FL. Waseem H, et al. Among authors: kelley v. Clin Neurol Neurosurg. 2015 Dec;139:199-205. doi: 10.1016/j.clineuro.2015.10.016. Epub 2015 Oct 23. Clin Neurol Neurosurg. 2015. PMID: 26513433

10

Laser ablation therapy: An alternative treatment for medically resistant mesial temporal lobe epilepsy after age 50.

Waseem H, Osborn KE, Schoenberg MR, Kelley V, Bozorg A, Cabello D, Benbadis SR, Vale FL. Waseem H, et al. Among authors: kelley v. Epilepsy Behav. 2015 Oct;51:152-7. doi: 10.1016/j.yebeh.2015.07.022. Epub 2015 Aug 13. Epilepsy Behav. 2015. PMID: 26280814

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

323 results

Search Page

Filters